FOLD
Amicus Therapeutics Inc.
$9.03
+$0.13(+1.46%)
58
Overall
20
Value
91
Tech
65
Quality
Market Cap
$2.57B
Volume
4.89M
52W Range
$5.51 - $12.65
Target Price
$15.36
EPS Estimates Overview
| Current Quarter | $0.05 | Next Quarter | $0.08 |
| Current Year | $0.03 | Next Year | $0.41 |
| QoQ Growth | +60.0% | YoY Growth | +1266.7% |
| 3Y EPS CAGR | +41.9% | Target Price | $15.36 |
| Consensus | Buy | Upside | +70.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FOLD | $9.03 | +1.5% | 4.89M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Amicus Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW